Zobrazeno 1 - 10
of 227
pro vyhledávání: '"S. Rinne"'
Autor:
Yongsheng Liu, Shengze Yu, Tianqi Xu, Vitalina Bodenko, Anna Orlova, Maryam Oroujeni, Sara S. Rinne, Vladimir Tolmachev, Anzhelika Vorobyeva, Torbjörn Gräslund
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1475 (2022)
The Insulin-like growth factor-1 receptor (IGF-1R) is a molecular target for several monoclonal antibodies undergoing clinical evaluation as anticancer therapeutics. The non-invasive detection of IGF-1R expression in tumors might enable stratificatio
Externí odkaz:
https://doaj.org/article/763389a92a5e486a9d66ef663045a10a
Publikováno v:
A35. LEVERAGING USE OF INFORMATICS AND TECHNOLOGY.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maryam Oroujeni, Tianqi Xu, Katherine Gagnon, Sara S. Rinne, Jan Weis, Javad Garousi, Ken G. Andersson, John Löfblom, Anna Orlova, Vladimir Tolmachev
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 292 (2021)
Epidermal growth factor receptor (EGFR) is overexpressed in many malignancies. EGFR-targeted therapy extends survival of patients with disseminated cancers. Radionuclide molecular imaging of EGFR expression would make EGFR-directed treatment more per
Externí odkaz:
https://doaj.org/article/e37a7216bdee47a5933c4ad6900b8e94
Autor:
Ayman Abouzayed, Sara S. Rinne, Hamideh Sabahnoo, Jens Sörensen, Vladimir Chernov, Vladimir Tolmachev, Anna Orlova
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 182 (2021)
Background: Gastrin-releasing peptide receptor (GRPR) is an important target for imaging of prostate cancer. The wide availability of single-photon emission computed tomography/computed tomography (SPECT/CT) and the generator-produced 99mTc can be ut
Externí odkaz:
https://doaj.org/article/ad4c3290942e443388cfb165dffb4c8f
Autor:
Vladimir Chernov, Anastasiya Rybina, Roman Zelchan, Anna Medvedeva, Olga Bragina, Nadejda Lushnikova, Artem Doroshenko, Evgeniy Usynin, Liubov Tashireva, Sergey Vtorushin, Ayman Abouzayed, Sara S. Rinne, Jens Sörensen, Vladimir Tolmachev, Anna Orlova
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1631
The gastrin-releasing peptide receptor (GRPR) is overexpressed in prostate cancer (PCa) and in hormone-driven breast cancer (BCa). The aim of this phase I clinical trial was to evaluate safety, biodistribution, and dosimetry after the administration
Autor:
Tianqi Xu, Alexey Schulga, Elena Konovalova, Sara S. Rinne, Hongchao Zhang, Olga Vorontsova, Anna Orlova, Sergey M. Deyev, Vladimir Tolmachev, Anzhelika Vorobyeva
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 2838
Volume 24
Issue 3
Pages: 2838
Pancreatic cancer (PC) is one of the most aggressive malignancies. A combination of targeted therapies could increase the therapeutic efficacy in tumors with heterogeneous target expression. Overexpression of the human epidermal growth factor recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e42011769d21b9384798a372733576
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-498128
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-498128
Autor:
Ayman Abouzayed, Hanna Tano, Ábel Nagy, Sara S. Rinne, Fadya Wadeea, Sharmishtaa Kumar, Kristina Westerlund, Vladimir Tolmachev, Amelie Eriksson Karlström, Anna Orlova
Publikováno v:
Pharmaceutics, Vol 12, Iss 10, p 977 (2020)
The targeting of gastrin-releasing peptide receptors (GRPR) was recently proposed for targeted therapy, e.g., radiotherapy. Multiple and frequent injections of peptide-based therapeutic agents would be required due to rapid blood clearance. By conjug
Externí odkaz:
https://doaj.org/article/d25f32a395b44c4fa313e977f06c4356
Autor:
Anzhelika Vorobyeva, Maryam Oroujeni, Sarah Lindbo, Sophia Hober, Tianqi Xu, Yongsheng Liu, Sara S. Rinne, Javad Garousi
Publikováno v:
Molecules, Vol 25, Iss 19, p 4448 (2020)
Albumin binding domain-Derived Affinity ProTeins (ADAPTs) are small (5 kDa) engineered scaffold proteins that are promising targeting agents for radionuclide-based imaging. A recent clinical study has demonstrated that radiolabeled ADAPTs can efficie
Externí odkaz:
https://doaj.org/article/de10d4c1d3a6430bb50953b24a9a84b0